FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Murillo

Research Profile

Procedures

Living Beings

Chemicals & Drugs

Geographic Areas

Midwestern United States

Disorders

Blood Group Incompatibility

Concepts & Ideas

Co-author Network

Publications

TOP 3
Christopher F Bryan; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo; M R Wakefield
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
Christopher F Bryan; Mark Wakefield; Jeffrey C Reese; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo
Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Christopher F Bryan; Scott B McDonald; Alan M Luger; Charles F Shield; Franz T Winklhofer; A Michael Borkon; Bradley A Warady; Mark I Aeder; Daniel Murillo
Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Murillo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Christopher F Bryan; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo; M R Wakefield
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1181-4.
2007: Christopher F Bryan; Mark Wakefield; Jeffrey C Reese; Charles F Shield; Bradley A Warady; Franz T Winklhofer; Daniel Murillo
Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Clinical transplantation 2007;21(1):72-9.
2006: Christopher F Bryan; Scott B McDonald; Alan M Luger; Charles F Shield; Franz T Winklhofer; A Michael Borkon; Bradley A Warady; Mark I Aeder; Daniel Murillo
Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.
Clinical transplantation 2006;20(5):563-70.
2005: Christopher F Bryan; Franz T Winklhofer; Daniel Murillo; Gilbert Ross; Paul W Nelson; Charles F Shield; Bradley A Warady
Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.
Transplantation 2005;80(1):75-80.
2004: Christopher F Bryan; Paul W Nelson; Charles F Shield; Gilbert Ross; Bradley A Warady; Daniel Murillo; Franz T Winklhofer
Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
Clinical transplants 2004;():127-33.
2004: Christopher F Bryan; Gary E Tegtmeier; Nour Rafik; Lori E Markham; Daniel Murillo; Paul W Nelson; Charles F Shield; Bradley A Warady; Mark I Aeder
The risk for Chagas' disease in the Midwestern United States organ donor population is low.
Clinical transplantation 2004;18 Suppl 12():12-5.
2003: Christopher F Bryan; Kevin M Harrell; Stanley I Mitchell; Bradley A Warady; Mark I Aeder; Alan M Luger; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield
HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(4):459-64.
2003: Karen A Baier; L E Markham; S P Flaigle; Paul W Nelson; Charles F Shield; Nicolas A Muruve; Mark I Aeder; Daniel Murillo; Christopher F Bryan
Point-of-care testing in an organ procurement organization donor management setting.
Clinical transplantation 2003;17 Suppl 9():48-51.
2002: Christopher F Bryan; Scott B McDonald; Karen A Baier; Alan M Luger; Mark I Aeder; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady
Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
Clinical transplantation 2002;16 Suppl 7():15-23.
2002: Paul W Nelson; Charles F Shield; Nicolas A Muruve; Daniel Murillo; Bradley A Warady; Mark I Aeder; Christopher F Bryan
Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(1):94-9.